Market Tracker

10/19 5:09pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.7195
Delayed Data
As of Oct 19
 +0.0045 / +0.63%
Today’s Change
0.43
Today|||52-Week Range
1.60
-41.50%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.72
Today’s open0.72
Day’s range0.70 - 0.73
Volume102,977
Average volume (3 months)391,303
Market cap$27.6M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-4.30%
P/E ratioNM
Price/Sales2.91
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...-0.04-1.63%
SNOASonoma Pharmaceutica...-0.12-2.53%
OCRXOcera Therapeutics I...-0.02-2.21%
PRANPrana Biotechnology ...+0.64+24.52%
Data as of 4:00pm ET, 10/19/2017

Financials

Last reporting dateAugust 31, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$8.9M
Annual profit (last year)-$29.4M
Net profit margin-330.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts